TrueCar, Inc.

TrueCar, Inc. (NASDAQ: TRUE) related to its sale to Fair Holdings, Inc. Upon completion of the proposed transaction, TrueCar shareholders will receive $2.55 in cash per share.

Maywood Acquisition Corp.

Maywood Acquisition Corp. (NASDAQ: MAYA) related to its merger with GOWell Technology Limited. Upon completion of the proposed transaction, Maywood shareholders will receive shares in the newly combined company based on an exchange ratio.

Astria Therapeutics, Inc.

Astria Therapeutics, Inc. (NASDAQ: ATXS) related to its sale to BioCryst Pharmaceuticals, Inc. Under the terms of the proposed transaction, Astria shareholders will receive $8.55 in cash per share and 0.59 shares of BioCryst common stock per Astria share.

Rayonier Inc.

Rayonier Inc. (NYSE: RYN) related to its merger with PotlatchDeltic Corporation. Upon completion of the proposed transaction, Rayonier shareholders will own approximately 54% of the combined company.

PotlatchDeltic Corporation

PotlatchDeltic Corporation (NASDAQ: PCH) related to its sale to Rayonier Inc. Under the terms of the proposed transaction, PotlatchDeltic shareholders will receive 1.7339 common shares of Rayonier for each share of common stock of PotlachDeltic. Upon completion of the proposed transaction, PotlatchDeltic shareholders will own approximately 46% of the combined company

SWK Holdings Corporation

SWK Holdings Corporation (NASDAQ: SWKH) related to its sale to Runway Growth Finance Corp. Under the terms of the proposed transaction, SWK shareholders will receive, for each share of SWK common stock, either (i) cash consideration equal to SWK’s per-share net asset value (“NAV”), or (ii) Runway stock consideration based on the ratio of SWK’s … Read more

Akero Therapeutics, Inc.

Akero Therapeutics, Inc. (NASDAQ: AKRO) related to its sale to Novo Nordisk A/S. Under the terms of the proposed transaction, Akero shareholders will receive $54.00 per share in cash, and a non-transferable contingent value right entitling its holder to receive a cash payment of $6.00 per share upon full U.S. regulatory approval of efruxifermin by … Read more

Sapiens International Corporation N.V.

Sapiens International Corporation N.V. (NASDAQ: SPNS) related to its sale to Advent. Under the terms of the proposed transaction, Sapiens shareholders will receive $43.50 in cash per share.

Semler Scientific, Inc.

Semler Scientific, Inc. (NASDAQ: SMLR) related to its sale to Strive, Inc. Upon completion of the proposed transaction, Semler shareholders will receive 21.05 Class A common shares of Strive per share of Semler.

Union Pacific Corporation

Union Pacific Corporation (NYSE: UNP) related to its sale merger with Norfolk Southern Corporation. Upon completion of the transaction, Norfolk Southern shareholders will receive 1.0 Union common stock and $88.82 in cash per share.